Yazar "Emmungil, H." seçeneğine göre listele
Listeleniyor 1 - 6 / 6
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe BIOSIMILAR INFLIXIMAB EXPERIENCE IN SPONDYLOARTRITIS PATIENTS: TREASURE REAL LIFE RESULTS(Bmj Publishing Group, 2020) Bilge, N. S. Yasar; Kasifoglu, T.; Kiraz, S.; Ertenli, A. I.; Dalkilic, E.; Bes, C.; Emmungil, H.[Abstract Not Available]Öğe THE CLINICAL AND DEMOGRAPHIC FEATURES OF RELAPSING POLYCHONDRITIS: A NATIONWIDE STUDY(Bmj Publishing Group, 2016) Emmungil, H.; Erden, A.; Kucuksahin, O.; Zengin, O.; Ermurat, S.; Gok, K.; Dogru, A.[Abstract Not Available]Öğe CYCLOPHOSPHAMIDE INDUCED BLADDER TOXICITY AND PROTECTIVE EFFECT OF 2-MERCAPTOETHANE SULFONATE (MESNA) IN SYSTEMIC AUTOIMMUNE DISORDERS(Bmj Publishing Group, 2013) Yilmaz, N.; Emmungil, H.; Ozen, G.; Yildiz, F.; Dogan, I.; Balkarli, A.; Yasar, S.[Abstract Not Available]Öğe EXTREMELY LOW FREQUENCY OF CHRONIC HEPATITIS B INFECTION IN SYSTEMIC LUPUS ERYTHEMATOSUS(Bmj Publishing Group, 2023) Ademoglu, Z.; Ilgen, U.; Kalkan, K. Erol; Bilge, N. S. Yasar; Kasifoglu, T.; Emmungil, H.[Abstract Not Available]Öğe THE IMPORTANCE OF SPECKLE TRACKING ECHOCARDIOGRAPHY IN THE EVALUATION OF CARDIAC FUNCTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS(Bmj Publishing Group, 2020) Ebik, M.; Tastekin, N.; Gurdogan, M.; Ebik, M.; Birtane, M.; Emmungil, H.; Yilmazer, B.[Abstract Not Available]Öğe Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide(Clinical & Exper Rheumatology, 2015) Yilmaz, N.; Emmungil, H.; Gucenmez, S.; Ozen, G.; Yildiz, F.; Balkarli, A.; Kimyon, G.[Abstract Not Available]
